This article was originally published in the Cosmetics Business Skin Care Trend Report. Receive your copy here.
“Peptides are the buzzword of the year,” stated board-certified dermatologist Dr Lindsay Zubritsky at Clinique’s latest launch event.
And judging by the extent of innovation focusing on their wide ranging benefits, it seems the entire skin care industry would agree.
Yet, peptides – short chains of amino acids that make up proteins needed for the skin to function at its best – first exploded onto the skin care scene in the early 2000s.
This was when Matrixyl 3000 and Argireline launched, peptides that became widely used by brands across the board from Olay to Chanel.
The Ordinary’s Multi-Peptide + HA Serum (formerly ‘Buffet’) which includes Argireline, Matrixyl 3000, and two further peptides has been a consistent best seller for years.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.
- Companies:
- Estée Lauder Companies
- University of Manchester
- Galderma
- Deciem
- Be For Innovation
